ESSA Pharma Inc. (EPIX)
| Previous close | 6.25 |
| Open | 6.22 |
| Bid | 4.56 x 200 |
| Ask | 7.53 x 200 |
| Day's range | 5.84 - 6.40 |
| 52-week range | 2.58 - 11.67 |
| Volume | |
| Avg. volume | 78,027 |
| Market cap | 276.046M |
| Beta (5Y monthly) | 1.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.59 |
| Earnings date | 10 May 2024 - 15 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.00 |
PR NewswireESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024 at 2:30 p.m. ET in Toronto, Canada.
Simply Wall St.ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
PR NewswireESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held virtually on March 6, 2024 (the "Meeting").
